Company Overview and News

38
Top 10 Net Payout Yields - September 2018

1h seekingalpha
The top net payout yield stocks had a 5.0% gain in August, outperforming the S&P 500 index.
NXT LBTY WBA NXPI CTL SYLD LBTYK KR LILAB AMAT CELG CSCO CSCOI EBAY GLW DFS C LBTYB LBTYA BBY MU LILAK QCOM LILA

5
NXP Semiconductors Announces US$1 Billion Bridge Financing

2018-09-20 globenewswire - 1
EINDHOVEN, The Netherlands, Sept. 20, 2018 (GLOBE NEWSWIRE) -- NXP Semiconductors N.V. (NASDAQ: NXPI) today announced that on September 19, 2018 (the “Closing Date”) its subsidiaries NXP B.V and NXP Funding LLC (the “Borrowers”), the lenders party thereto and Barclays Bank Plc, as administrative agent, entered into a US$1,000,000,000 senior unsecured bridge term credit facility agreement (the “Bridge Term Credit Agreement”).
83SF BCS OIL 83SK NXPI 47MC

4
NXPI / NXP Semiconductors N.V. 6-K (Current Report of Foreign Issuer)

2018-09-20 sec.gov
6-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 NXPI

4
NXP Semiconductors and Hitachi Solutions Collaborate on Secure DSRC-based V2X Solution for Japanese Market

2018-09-17 globenewswire
COPENHAGEN, Denmark, Sept. 17, 2018 (GLOBE NEWSWIRE) -- NXP Semiconductors N.V. (NASDAQ: NXPI), the world’s largest supplier of automotive semiconductors1, and Hitachi Solutions, Ltd., a leader in V2X software platforms for the Japanese automotive market, have announced a partnership to develop a new V2X solution targeted at the Japanese market [J-ITS]. The solution will employ an NXP developed V2X modem and processor and a full Hitachi Solutions V2X software stack, providing automakers that target the Japanese market with a head start in the development of their own V2X solutions, whether they are on board units (OBUs) or full Telematics Modules.
NXPI

5
NXPI / NXP Semiconductors N.V. S-8

2018-09-14 sec.gov - 1
S-8 As filed with the Securities and Exchange Commission on September 14, 2018 Registration Number 333-
NXPI

4
NXP Semiconductors NV (NXPI) Presents at Deutsche Bank 2018 Technology Conference Call Transcript

2018-09-14 seekingalpha
NXP Semiconductors NV (NASDAQ:NXPI) Deutsche Bank 2018 Technology Conference Call September 13, 2018 2:20 PM ET
DB NXPI

58
5 Top Stock Trades for Friday — How to Trade Adobe’s Earnings

2018-09-14 investorplace - 1
It’s been a good week for the bulls, as U.S. equities have been slowly-but-surely charging higher. It’s left many investors wondering what to do and if there are any opportunities left. Let’s look at our top stock trades to get an idea at what still exists.
FB TWTR AAPL NXPI AMD ADBE SNAP

18
Snap, NXP Semiconductor Dive into Wednesday’s 52-Week Low Club

2018-09-12 247wallst - 1
September 12, 2018: Here are four stocks trading with heavy volume among 136 equities making new 52-week lows in Wednesday’s session. On the NYSE advancers led decliners by about 1.32 to 1, and on the Nasdaq, decliners led advancers by about 1.09 to 1.
VTL AMAT NXPI SNAP

18
Why Goldman Sachs and Others See More Weakness Across Semiconductor Sector

2018-09-12 247wallst
If you have been tracking the activity in technology stocks in recent weeks, it has been hard to not notice the meltdown that has taken place in the various areas tied to semiconductors. What was running as an industry in supply shortages has started to become an industry facing oversupply. It’s a cycle that has happened dozens of times over the decades, but 24/7 Wall St. recently warned its readers that the analyst downgrades were probably far from being over, after seeing that the consensus analyst price targets were all still way too optimistic.
LRCX ENTG MU AAPL NXPI WDC STX 8035 TOELF MXIM POWI TOELY

10
Broadcom: Resilient Quarter, Aggressive Management

2018-09-12 seekingalpha - 1
This makes that the dip following the announcement of the purchase of CA has proven to be a good buying opportunity, as the company itself completed huge buybacks.
AVGO NXPI QCOM CA

17
The Run in Qualcomm Stock Looks to Be at an End

2018-09-11 investorplace
It’s been an interesting year for Qualcomm (NASDAQ:QCOM), to say the least. A takeover by Qualcomm failed, and so did a takeover of Qualcomm stock. With M&A uncertainty ended, however, QCOM stock has rallied nicely, climbing 44% from April lows. A current price around $70 is just shy of a three-year high.
MTSI MU AVGO AAPL NXPI NVDA QCOM INTC

10
NXPI / NXP Semiconductors N.V. 6-K (Current Report of Foreign Issuer)

2018-09-11 sec.gov - 6
6-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 NXPI

26
Trapeze Asset Management Q2 2018 Letter: The Quality Quandary

2018-09-11 seekingalpha
As value investors, we are always on the lookout for bargains - stocks or bonds that are trading at prices below our estimate of Fair Market Value (FMV). Both research and common sense dictate that the greater the discrepancy between price and FMV, the better it provides a higher possible margin of safety and implied upside. However, securities are often detached from their FMVs because the business is suffering, leaving investors to figure out whether the issues at hand will be minor and temporary or debilitating and permanent.
NPSNY SIEGY KGI.DB NXPI HUSKF MTLHY HPE DLTR HSE TJX MTLHF SWK 4188 BIDU ORCL KL BUD KGI KGI.DB.A WDO ASR TAP BABA 0700 AHBIF HPQ WDOFF DMLRY QCOM

6
NXP Semiconductors Announces the Initiation of a Quarterly Dividend Program

2018-09-10 globenewswire - 2
EINDHOVEN, The Netherlands, Sept. 10, 2018 (GLOBE NEWSWIRE) -- NXP Semiconductors N.V. (NASDAQ: NXPI) today announced that its board of directors has approved the initiation of a dividend program under which the company will pay a regular quarterly cash dividend. The initial interim dividend for the fourth quarter of 2018 will be $ 0.25 per ordinary share. The interim dividend will be paid on October 5, 2018 to shareholders of record as of September 25, 2018.
NXPI

4
NXP's A71CH Trust Anchor Solution Delivers Secure Connections to Google Cloud IoT Core

2018-09-10 globenewswire
Collaboration brings “zero-touch” onboarding of devices to Google Cloud IoT with NXP A71CH, Plug & Trust Secure Element
NXPI

Related Articles

RIGL: Rigel Pharmaceuticals Analysis and Research Report

2018-09-18 - Asif

Overview Rigel Pharmaceuticals is a biotechnology company dedicated to discovering, developing and providing novel small molecule drugs that significantly improve the lives of patients with immune and hematologic disorders, cancer and rare diseases. The company's pioneering research focuses on signaling pathways that are critical to disease mechanisms. The company's first FDA-approved product is TAVALISSE™ (fostamatinib disodium hexahydrate), an oral spleen tyrosine kinase (SYK) inhibitor, for the treatment of adult patients with chronic immune thrombocytopenia who have had an insufficient response to a previous treatment. The company's current clinical programs include Phase 2 studies of fostamatinib in autoimmune hemolytic anemia and IgA nephropathy, and a Phase 1 study for its IRAK program. In addition, Rigel Pharmaceuticals has product candidates in development with partners BerGenBio AS, Daiichi Sankyo, and Aclaris Therapeutics. Since inception, Rigel Pharmaceuticals h...

EKSO: Ekso Bionics Holdings Analysis and Research Report

2018-09-18 - Asif

Overview The company design, develop and sell exoskeleton technology to augment human strength, endurance and mobility. The company's exoskeleton technology serves multiple markets and can be used both by able-bodied users as well as by persons with physical disabilities. Ekso Bionics has sold, rented or leased devices that (a) enable individuals with neurological conditions affecting gait (stroke and spinal cord injury) to rehabilitate and to walk again and (b) allow industrial workers to perform heavy duty work for extended periods. Today, its medical exoskeleton, Ekso GT, is used as a rehabilitation tool to allow physicians and therapists to rehabilitate patients who have suffered a stroke or spinal cord injury. With its unique features designed specifically for hospitals and its proprietary SmartAssist software, Ekso GT allows for the early mobilization of patients, with high step count and high dosage treatments. The intent is to allow the patient’s central nervous syst...

AGRX: Agile Therapeutics Analysis and Research Report

2018-09-18 - Asif

Overview Agile Therapeutics is a forward-thinking women’s healthcare company dedicated to fulfilling the unmet health needs of today’s women. Twirla® and its other current potential product candidates are designed to provide women with contraceptive options that offer greater convenience and facilitate compliance. The company's lead product candidate, Twirla, also known as AG200-15, is a once-weekly prescription contraceptive patch that is at the end of Phase 3 clinical development. Since its inception in 1997, Agile Therapeutics has devoted substantial resources to developing Twirla, building its intellectual property portfolio, business planning, raising capital and providing general and administrative support for these operations. The company incurred research and development expenses of $14.4 million, $20.9 million and $25.6 million during the years ended December 31, 2017, 2016 and 2015, respectively. The company incurred research and development expenses of $2.4 milli...

Silicon Investor Message Boards

This table lists all message boards related to NXPI / NXP Semiconductors N.V. on message board site Silicon Investor.

NXPI after Qualcomm failed bid NXPI after Qualcomm failed bid NXPI after Qualcomm failed bid NXP Semiconductor NXP Semiconductor NXP Semiconductor
CUSIP: N6596X109